Limited time75% off all plans
Get the app

Contrast-Enhanced Ultrasound

Contrast-Enhanced Ultrasound

Contrast-Enhanced Ultrasound

On this page

CEUS Fundamentals - Bubble Science 101

  • Microbubbles (MBs):
    • Gas-filled (e.g., Perfluorocarbon, $SF_6$) microspheres.
    • Encapsulated by a shell (e.g., lipid, albumin, polymer).
    • Size: 1-10 µm (similar to Red Blood Cells); remain strictly intravascular.
    • Highly echogenic due to large acoustic impedance mismatch with blood.
  • Mechanism of Action:
    • MBs resonate (oscillate) when insonated by ultrasound waves.
    • Emit non-linear harmonic signals, which are preferentially detected by the transducer.
    • Harmonic imaging significantly improves signal-to-noise ratio and reduces artifacts.
    • Can be intentionally destroyed by high Mechanical Index (MI) ultrasound pulses (useful for perfusion quantification).
  • Key Advantages:
    • Real-time dynamic assessment of vascularity and perfusion.
    • No nephrotoxicity (safe in patients with renal impairment).
    • No ionizing radiation.

⭐ Microbubbles are purely intravascular agents. Their inability to pass into the normal interstitium is crucial for differentiating vascular patterns and assessing perfusion dynamics, unlike iodinated or gadolinium-based contrast agents which can extravasate more readily into the extravascular extracellular space (EES).

Contrast Agents - The Bubbly Crew

  • Composition & Size:
    • Gas-filled microbubbles (2-10 µm).
    • Shell: Lipid, albumin, polymer.
    • Gas: Perfluorocarbons, $SF_6$.
  • Key Properties:
    • Strictly intravascular (no interstitial leakage).
    • High echogenicity (impedance mismatch).
    • Non-linear oscillation → harmonic imaging.
  • Pharmacokinetics:
    • Route: IV.
    • Elimination: Gas exhaled (lungs); shell metabolized.
    • Half-life: Short (minutes).
  • Safety & Adverse Effects:
    • Generally safe; no nephrotoxicity.
    • ⚠️ Contraindications: Severe cardiopulmonary disease (R-L shunts, severe pulm HTN, unstable IHD).
    • Rare: Headache, nausea; anaphylactoid reactions (very rare).

⭐ Purely intravascular, unlike CT/MRI agents; ideal for real-time perfusion imaging without interstitial leakage.

Technique & Phases - Dynamic Dance

  • Injection & Imaging:
    • IV bolus: Microbubble contrast agents (e.g., sulfur hexafluoride).
    • Crucial: Low Mechanical Index (MI < 0.4) to preserve bubbles for dynamic scan.
    • Continuous real-time visualization.
  • Dynamic Phases (Sequential Assessment):
    • Arterial Phase: 10-30 seconds post-injection. Shows early vascular filling, lesion hyperenhancement.
    • Portal Venous Phase: 30-120 seconds. Peak organ (e.g., liver, spleen) parenchymal enhancement.
    • Late Phase: >120 seconds (up to 4-6 minutes). Key for washout patterns (e.g., HCC vs. benign). 📌 Mnemonic: Always Probe Lesions (Arterial, Portal, Late)

⭐ CEUS is invaluable for characterizing focal liver lesions, especially when CT/MRI contrast is contraindicated (e.g., severe renal impairment, contrast allergy).

Clinical Applications - CEUS Detective

CEUS Enhancement Patterns of Benign Focal Liver Lesions

  • Liver Lesion Characterization (Primary Use):
    • Hepatocellular Carcinoma (HCC): APHE + portal/late phase washout (LR-M criteria).
    • Metastases: Often rim APHE, then rapid & marked washout.
    • Hemangioma: Peripheral nodular enhancement, centripetal fill (often incomplete on CEUS).
    • Focal Nodular Hyperplasia (FNH): Spoke-wheel arterial filling, sustained enhancement in portal/late phases.
    • Abscess: Honeycomb pattern, non-enhancing center, peripheral rim enhancement.
  • Renal Lesions:
    • Cystic vs. solid differentiation.
    • RCC vascularity assessment.
  • Other Key Areas:
    • Splenic infarcts/lesions.
    • Pancreatic lesion assessment.
    • Trauma: Solid organ injury (liver, spleen, kidney).
    • Vascular: Pseudoaneurysms, endoleaks, TIPS.
    • Biopsy/ablation guidance.

⭐ Key advantage: Safe in renal impairment & contrast allergy, crucial for liver lesion workup when CECT/MRI contraindicated.

High‑Yield Points - ⚡ Biggest Takeaways

  • CEUS uses microbubble contrast agents; strictly intravascular.
  • Enables real-time dynamic assessment of tissue perfusion and vascularity.
  • Key for characterizing focal liver lesions (e.g., FNH, HCC) and renal masses.
  • Washout patterns (e.g., late washout in HCC) are critical for diagnosis.
  • Safer profile than CT/MRI contrast; low nephrotoxicity and allergic reaction risk.
  • Avoid in severe right-to-left cardiac shunts and severe pulmonary hypertension.
  • Differentiates tumor thrombus from bland thrombus effectively.

Continue reading on Oncourse

Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.

CONTINUE READING — FREE

or get the app

Rezzy — Oncourse's AI Study Mate

Have doubts about this lesson?

Ask Rezzy, your AI Study Mate, to explain anything you didn't understand

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

START FOR FREE